Business Wire
BusinessJim Cramer frames a “sudden” opportunity for Walmart, while pointing to Target as the stronger betThe Apex TimesBusinessJim Cramer links SpaceX’s AI compute narrative to Tesla’s earnings focus as SPCX trades near its IPO debutThe Apex TimesBusinessGoldman Sachs shifts its view of the U.S. economy as it expects interest rates to stay higherThe Apex TimesBusinessYahoo Finance reports traders are refocusing on Starlink, pressing telecom stocks including Verizon and its peersThe Apex TimesBusinessApple updates Final Cut Camera for iOS 27, adding variable aperture control and pro video toolsThe Apex TimesBusinessVisa shares face a simple question after recent gains: is the stock still pricing in the next leg of growth?The Apex TimesBusinessJeff Bezos says Amazon is still adjusting workforce size after pandemic hiring, with one decision lingeringThe Apex TimesBusinessBroadcom’s AVGO valuation debate shifts from AI momentum to cash-flow expectationsThe Apex TimesBusinessGoogle study in The Lancet tests AMIE medical AI before patients see a doctor, finding high alignment with cliniciansThe Apex TimesBusinessAmazon draws investor focus as it ramps up AI spending and delivery compensationThe Apex TimesBusinessPepsiCo holds onto food and beverage volume growth, even as margins and earnings remain under strainThe Apex TimesBusinessHome Depot names winners of its 2026 Innovation Awards for supplier product ideasThe Apex TimesBusinessJim Cramer frames a “sudden” opportunity for Walmart, while pointing to Target as the stronger betThe Apex TimesBusinessJim Cramer links SpaceX’s AI compute narrative to Tesla’s earnings focus as SPCX trades near its IPO debutThe Apex TimesBusinessGoldman Sachs shifts its view of the U.S. economy as it expects interest rates to stay higherThe Apex TimesBusinessYahoo Finance reports traders are refocusing on Starlink, pressing telecom stocks including Verizon and its peersThe Apex TimesBusinessApple updates Final Cut Camera for iOS 27, adding variable aperture control and pro video toolsThe Apex TimesBusinessVisa shares face a simple question after recent gains: is the stock still pricing in the next leg of growth?The Apex TimesBusinessJeff Bezos says Amazon is still adjusting workforce size after pandemic hiring, with one decision lingeringThe Apex TimesBusinessBroadcom’s AVGO valuation debate shifts from AI momentum to cash-flow expectationsThe Apex TimesBusinessGoogle study in The Lancet tests AMIE medical AI before patients see a doctor, finding high alignment with cliniciansThe Apex TimesBusinessAmazon draws investor focus as it ramps up AI spending and delivery compensationThe Apex TimesBusinessPepsiCo holds onto food and beverage volume growth, even as margins and earnings remain under strainThe Apex TimesBusinessHome Depot names winners of its 2026 Innovation Awards for supplier product ideasThe Apex TimesBusinessJim Cramer frames a “sudden” opportunity for Walmart, while pointing to Target as the stronger betThe Apex TimesBusinessJim Cramer links SpaceX’s AI compute narrative to Tesla’s earnings focus as SPCX trades near its IPO debutThe Apex TimesBusinessGoldman Sachs shifts its view of the U.S. economy as it expects interest rates to stay higherThe Apex TimesBusinessYahoo Finance reports traders are refocusing on Starlink, pressing telecom stocks including Verizon and its peersThe Apex TimesBusinessApple updates Final Cut Camera for iOS 27, adding variable aperture control and pro video toolsThe Apex TimesBusinessVisa shares face a simple question after recent gains: is the stock still pricing in the next leg of growth?The Apex TimesBusinessJeff Bezos says Amazon is still adjusting workforce size after pandemic hiring, with one decision lingeringThe Apex TimesBusinessBroadcom’s AVGO valuation debate shifts from AI momentum to cash-flow expectationsThe Apex TimesBusinessGoogle study in The Lancet tests AMIE medical AI before patients see a doctor, finding high alignment with cliniciansThe Apex TimesBusinessAmazon draws investor focus as it ramps up AI spending and delivery compensationThe Apex TimesBusinessPepsiCo holds onto food and beverage volume growth, even as margins and earnings remain under strainThe Apex TimesBusinessHome Depot names winners of its 2026 Innovation Awards for supplier product ideasThe Apex TimesBusinessJim Cramer frames a “sudden” opportunity for Walmart, while pointing to Target as the stronger betThe Apex TimesBusinessJim Cramer links SpaceX’s AI compute narrative to Tesla’s earnings focus as SPCX trades near its IPO debutThe Apex TimesBusinessGoldman Sachs shifts its view of the U.S. economy as it expects interest rates to stay higherThe Apex TimesBusinessYahoo Finance reports traders are refocusing on Starlink, pressing telecom stocks including Verizon and its peersThe Apex TimesBusinessApple updates Final Cut Camera for iOS 27, adding variable aperture control and pro video toolsThe Apex TimesBusinessVisa shares face a simple question after recent gains: is the stock still pricing in the next leg of growth?The Apex TimesBusinessJeff Bezos says Amazon is still adjusting workforce size after pandemic hiring, with one decision lingeringThe Apex TimesBusinessBroadcom’s AVGO valuation debate shifts from AI momentum to cash-flow expectationsThe Apex TimesBusinessGoogle study in The Lancet tests AMIE medical AI before patients see a doctor, finding high alignment with cliniciansThe Apex TimesBusinessAmazon draws investor focus as it ramps up AI spending and delivery compensationThe Apex TimesBusinessPepsiCo holds onto food and beverage volume growth, even as margins and earnings remain under strainThe Apex TimesBusinessHome Depot names winners of its 2026 Innovation Awards for supplier product ideasThe Apex Times
Back to front
Aetna says 69% of its Medicare Advantage members are in 2027 plans rated 4 stars or higher by CMS
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 8, 6:13 PM EDT

Aetna says 69% of its Medicare Advantage members are in 2027 plans rated 4 stars or higher by CMS

CVS Health’s Aetna attributed its 2027 Medicare Advantage performance to clinical quality and member experience, as federal “Star Ratings” reflect plan results for care and service.

Aetna, the Medicare Advantage insurer within CVS Health, said it expects a majority of its Medicare Advantage (MA) members to be in 2027 plans that receive strong performance scores under the Centers for Medicare & Medicaid Services’ annual Star Ratings. In a statement carried by Yahoo Finance, Aetna said more than 69% of its MA members are in 2027 plans rated 4 stars or higher on a five-star scale, with the company linking the result to “clinical quality” and “member experience.”

The CMS Star Ratings are a widely watched yardstick for MA plans. The program scores plans on multiple measures tied to healthcare outcomes and patient experience, then assigns an overall rating from 1 to 5 stars for the upcoming year. Higher-rated plans can qualify for greater bonus payments under federal rules, and the ratings also influence how consumers compare plans during open enrollment.

Aetna positioned its 2027 results as evidence that its approach is translating into measurable quality and service. The company’s framing emphasizes two themes that are closely aligned with how Star Ratings are constructed: the quality of care delivered and the experience members report when they seek services, coordinate coverage, or interact with the plan.

The announcement does not, in the excerpt available here, break out the distribution of ratings by star level, disclose which specific performance categories contributed most, or provide historical year-over-year comparisons. It also does not specify the total number of Aetna MA members covered by the 2027 rated plans, beyond the share figure it reported.

Aetna is required to participate in the MA program as it competes for Medicare enrollment. For insurers, the annual ratings matter because they can affect both the economics of the business and the competitive perception of plan quality. Within CVS Health, Aetna is one of the company’s central healthcare platforms, and MA membership is an important driver of how the health insurance segment performs throughout the year.

The timing of CMS Star Ratings also shapes operational decisions for insurers. After ratings are released, plans typically adjust outreach, provider engagement, and member support processes intended to address the measures that pull down scores. Aetna’s emphasis on clinical quality and member experience suggests it is aiming to sustain or improve factors CMS evaluates, rather than focusing only on administrative compliance.

Even with a strong headline share, the ultimate impact depends on how CMS finalizes payments and on how other parts of an insurer’s portfolio perform. The post does not provide further details on contract-level economics, risk adjustment trends, or the size and mix of Aetna’s Medicare Advantage product offerings within those rated plans.

What to watch next is whether Aetna and CVS Health expand on the underlying drivers behind the 2027 ratings in more complete disclosures, such as which categories improved, how the company’s ratings compare to prior years, and what specific member or clinical programs are tied to the performance. Insurers often provide more granular color around Star Rating outcomes after the initial announcement, particularly in investor materials and earnings communications.

Why It Matters

  • CMS Star Ratings are a key benchmark for Medicare Advantage plans, reflecting both quality of care and member experience.
  • Higher-rated plans can be tied to financial incentives under federal MA rules, which makes plan performance relevant to insurers’ earnings outlook.
  • Aetna’s reported share of members in 4-plus star plans indicates a strong concentration of enrollment in higher-scoring offerings, which can affect competitive positioning during enrollment season.
  • The emphasis on clinical quality and member experience suggests Aetna may continue investing in programs aimed at the measures CMS uses for scoring.

Sources

Key Facts

  • Aetna, part of CVS Health, reported that more than 69% of its 2027 Medicare Advantage members are in plans rated 4 stars or higher.
  • The ratings referenced are CMS MA Star Ratings, on a scale from 1 to 5 stars.
  • Aetna attributed its 2027 Star Rating performance to clinical quality and member experience.
  • The report is focused on plan ratings for 2027, which are set through CMS’ annual Star Ratings process.

Healthcare Related